Activist 13D/13G Filings - Sofinnova Venture Partners IX L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2024-02-20
6:57 pm
Sale		13DGALERA THERAPEUTICS INC
GRTX		Sofinnova Venture Partners IX L.P.0
0.000%		-3,083,712decrease
(Position Closed)		View
2023-02-03
7:04 pm
Sale		13DGALERA THERAPEUTICS INC
GRTX		Sofinnova Venture Partners IX L.P.3,083,712
10.800%		-1,098decrease
(-0.04%)		View
2021-03-04
06:17 am
Sale		13DEntasis Therapeutics Holdings Inc.
ETTX		Sofinnova Venture Partners IX L.P.0
0.000%		-1,180,178decrease
(Position Closed)		View
2020-08-19
11:58 am
Purchase		13DCheckmate Pharmaceuticals Inc.
CMPI		Sofinnova Venture Partners IX L.P.3,606,707
16.800%		3,606,707increase
(New Position)		View
2020-06-05
4:48 pm
Sale		13DITERUM THERAPEUTICS PLC SHS NE
ITRM		Sofinnova Venture Partners IX L.P.6,154
0.000%		-1,726,514decrease
(-99.64%)		View
2020-04-27
1:04 pm
Sale		13DMERUS N V COM
MRUS		Sofinnova Venture Partners IX L.P.1,311,039
4.500%		-439,060decrease
(-25.09%)		View
2020-02-13
1:26 pm
Unchanged		13GCHIASMA INC
CHMA		Sofinnova Venture Partners IX L.P.1,767,102
4.200%		0
(Unchanged)		View
2020-01-24
9:51 pm
Purchase		13DITERUM THERAPEUTICS PLC SHS NE
ITRM		Sofinnova Venture Partners IX L.P.1,732,668
11.600%		6,154increase
(+0.36%)		View
2019-11-21
8:05 pm
Purchase		13DNEXTCURE INC
NXTC		Sofinnova Venture Partners IX L.P.2,671,856
10.000%		150,000increase
(+5.95%)		View